CTFA guidelines
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic, Toiletry and Fragrance Association is requesting public comments on two new and one revised Safety Evaluation Guidelines by July 8, CTFA announces. The two new guidelines for genotoxicity and reproductive and developmental toxicity testing describe both in vivo and in vitro models, while the revised guidelines on photoirritation/photoallergy include in vivo, in vitro and clinical test methods, association notes. CTFA Safety Evaluation Guidelines "provide manufacturers with guidance regarding the use of preclinical and clinical safety testing as means to substantiate the safety of both ingredients and finished cosmetic products"...
You may also be interested in...
CTFA guidelines
The Cosmetic, Toiletry and Fragrance Association is requesting comments on a new Safety Evaluation Guideline on in vitro test methods for evaluating skin absorption; comments are due by Sept. 25. The association's guidelines "provide manufacturers with guidance regarding the use of preclinical and clinical safety testing as a means to substantiate the safety of both ingredients and finished cosmetic products." In June, CTFA requested comments on two new guidelines for genotoxicity and reproductive and developmental toxicity testing as well as revised guidelines on photoirritation/photoallergy (1"The Rose Sheet" June 26, 2006, In Brief)...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.